Market Overview:
The global autotransfusion devices market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of trauma and surgeries, rising demand for minimally invasive surgeries, and technological advancements in autotransfusion devices. Based on type, the global autotransfusion devices market is segmented into on pump transfusion devices and off pump transfusion devices. On pump transfusiondevices are further sub-segmented into centrifugal pumps and positive displacement pumps. Off pump transfusionsdevices are further sub-segmented into manual methodsand automated methods.
Product Definition:
An autotransfusion device is a medical device that uses centrifugal force to separate blood cells from plasma. The separated cells are then reinfused into the patient's bloodstream. Autotransfusion devices are used to treat conditions such as anemia, leukemia, and sickle cell anemia. They are also used to prevent or treat complications associated with blood transfusions, such as transfusion-associated lung injury (TRALI) and transfusion-related acute lung injury (TRALI).
On Pump Transfusion Devices:
On pump transfusion devices market is expected to grow at a lucrative rate during the forecast period. The growth of this market can be attributed to factors such as increasing demand for blood and its components, rising prevalence of chronic diseases leading to an increase in hospital admissions, growing geriatric population base and increasing awareness regarding autotransfusion devices.
Off Pump Transfusion Devices:
Off pump transfusion devices are used to transfer blood from a donor to the patient. It is also known as external cardiac blood pump or external centrifugal blood pumps. These devices are used in cases of severe bleeding and anemia where the patients cannot receive adequate RBCs or WBCs count from a donor.
Application Insights:
Based on application, the market is segmented into hospitals, ambulatory surgical centers, cardiac research centers and others. The hospital segment dominated the overall industry in terms of revenue in 2017. This high share can be attributed to factors such as a large patient base and increasing prevalence of chronic diseases that require frequent blood transfusion procedures for treatment. According to data published by International Society on Blood Transfusion (ISBT), an estimated 1 billion units of red cells are donated globally every year while over 400 million units of fresh frozen plasma (FFP) are required annually worldwide.
The cardiac research center application segment is expected to witness lucrative growth during the forecast period owing to rising number of cardiovascular disease cases globally coupled with technological advancements in autotransfusion devices that help reduce mortality rates associated with cardiopulmonary arrest caused due to inadequate blood flow through non-invasive methods such as pressure sensors.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing road accidents, rising prevalence of chronic diseases, and high geriatric population in the region. According to a study published by CDC National Center for Health Statistics (NCHS), from 2013 to 2016, approximately 6.3 million people died due to injuries caused by motor vehicle crashes in U.S.
Asia Pacific is expected to witness lucrative growth over the forecast period owing to factors such as improving healthcare infrastructure.
Growth Factors:
- Increasing incidence of trauma and road accidents: According to the World Health Organization (WHO), around 1.25 million people die each year as a result of road traffic crashes. This number is expected to grow in the coming years due to the increasing global population and rapid urbanization. The increasing incidence of trauma will lead to an increase in demand for autotransfusion devices, as they are used for blood transfusion in cases of severe hemorrhage.
- Growing awareness about autotransfusion: There is a growing awareness among healthcare professionals about the benefits of autotransfusion devices, which is likely to drive market growth over the forecast period.
- Technological advancements: The development of new and innovative autotransfusion devices is likely to spur market growth over the forecast period. These devices offer enhanced safety and efficiency compared with traditional methods such as centrifugation or bagging systems, thereby driving their adoption among healthcare professionals worldwide..
Scope Of The Report
Report Attributes
Report Details
Report Title
Autotransfusion Devices Market Research Report
By Type
On Pump Transfusion Devices, Off Pump Transfusion Devices
By Application
Hospitals, Ambulatory Surgical Centers, Cardiac Research Centers
By Companies
Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo Corporation, Stryker, Atrium Medical, Advancis Surgical, Fresenius Kabi
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
140
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Autotransfusion Devices Market Report Segments:
The global Autotransfusion Devices market is segmented on the basis of:
Types
On Pump Transfusion Devices, Off Pump Transfusion Devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Ambulatory Surgical Centers, Cardiac Research Centers
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Fresenius Kabi
- Haemonetics
- LivaNova
- Medtronic
- Terumo Corporation
- Stryker, Atrium Medical
- Advancis Surgical
- Fresenius Kabi
Highlights of The Autotransfusion Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- On Pump Transfusion Devices
- Off Pump Transfusion Devices
- By Application:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Research Centers
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Autotransfusion Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Autotransfusion devices are medical devices that help to transfuse blood and other fluids between different parts of the body.
Some of the major players in the autotransfusion devices market are Fresenius Kabi, Haemonetics, LivaNova, Medtronic, Terumo Corporation, Stryker, Atrium Medical, Advancis Surgical, Fresenius Kabi.
The autotransfusion devices market is expected to grow at a compound annual growth rate of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Autotransfusion Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Autotransfusion Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Autotransfusion Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Autotransfusion Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Autotransfusion Devices Market Size & Forecast, 2020-2028
4.5.1 Autotransfusion Devices Market Size and Y-o-Y Growth
4.5.2 Autotransfusion Devices Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 On Pump Transfusion Devices
5.2.2 Off Pump Transfusion Devices
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Ambulatory Surgical Centers
6.2.3 Cardiac Research Centers
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Autotransfusion Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Autotransfusion Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 On Pump Transfusion Devices
9.6.2 Off Pump Transfusion Devices
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Ambulatory Surgical Centers
9.10.3 Cardiac Research Centers
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 On Pump Transfusion Devices
10.6.2 Off Pump Transfusion Devices
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Ambulatory Surgical Centers
10.10.3 Cardiac Research Centers
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 On Pump Transfusion Devices
11.6.2 Off Pump Transfusion Devices
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Ambulatory Surgical Centers
11.10.3 Cardiac Research Centers
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 On Pump Transfusion Devices
12.6.2 Off Pump Transfusion Devices
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Ambulatory Surgical Centers
12.10.3 Cardiac Research Centers
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 On Pump Transfusion Devices
13.6.2 Off Pump Transfusion Devices
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Ambulatory Surgical Centers
13.10.3 Cardiac Research Centers
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Autotransfusion Devices Market: Competitive Dashboard
14.2 Global Autotransfusion Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Fresenius Kabi
14.3.2 Haemonetics
14.3.3 LivaNova
14.3.4 Medtronic
14.3.5 Terumo Corporation
14.3.6 Stryker, Atrium Medical
14.3.7 Advancis Surgical
14.3.8 Fresenius Kabi
